pyrroles has been researched along with Solitary Fibrous Tumors in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozzi, F; Casali, PG; Cominetti, D; Gronchi, A; Libertini, M; Messina, A; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Tortoreto, M; Zaffaroni, N | 1 |
| Casali, PG; Castelli, C; Colombo, C; Dagrada, P; Fiore, M; Gronchi, A; Huber, V; Negri, T; Pilotti, S; Rini, F; Rivoltini, L; Stacchiotti, S; Tazzari, M; Vergani, B; Villa, A | 1 |
| Badalamenti, G; Baldi, GG; Casali, PG; Cominetti, D; Dagrada, GP; Dei Tos, AP; Festinese, F; Fumagalli, E; Grignani, G; Gronchi, A; Morosi, C; Negri, T; Pennacchioli, E; Pilotti, S; Provenzano, S; Spagnuolo, RD; Stacchiotti, S; Tortoreto, M; Toss, A; Zaffaroni, N | 1 |
| Bozzi, F; Brenca, M; Brich, S; Castelli, C; Conca, E; Gloghini, A; Gualeni, AV; Maestro, R; Negri, T; Pierotti, MA; Pilotti, S; Spagnuolo, RD; Stacchiotti, S; Tazzari, M | 1 |
| Armand, JP; Domont, J; Lassau, N; Le Cesne, A; Massard, C; Soria, JC | 1 |
| Casali, PG; Conca, E; Gronchi, A; Messina, A; Morosi, C; Negri, T; Palassini, E; Pastorino, U; Pierotti, MA; Pilotti, S; Stacchiotti, S | 1 |
| Casali, PG; De Troia, B; Dei Tos, AP; Gronchi, A; Libertini, M; Marrari, A; Messina, A; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Stacchiotti, S | 1 |
2 trial(s) available for pyrroles and Solitary Fibrous Tumors
| Article | Year |
|---|---|
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.
Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Axitinib; Bevacizumab; Humans; Imidazoles; Indazoles; Indoles; Male; MAP Kinase Signaling System; Mice, SCID; Middle Aged; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Solitary Fibrous Tumors; Sorafenib; Sulfonamides; Sunitinib; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulins, Intravenous; Indoles; Male; Middle Aged; Neoplasm Metastasis; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Solitary Fibrous Tumors; Sunitinib; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2010 |
5 other study(ies) available for pyrroles and Solitary Fibrous Tumors
| Article | Year |
|---|---|
Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Female; Follow-Up Studies; Humans; Indazoles; Indoles; Male; Mice; Mice, SCID; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Prognosis; Pyrimidines; Pyrroles; Retrospective Studies; Solitary Fibrous Tumors; Sulfonamides; Sunitinib; Temozolomide; Xenograft Model Antitumor Assays | 2013 |
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.
Topics: Adaptive Immunity; Adult; Aged; Angiogenesis Inhibitors; Disease-Free Survival; Female; Humans; Immunosuppression Therapy; Indoles; Lymphocytes; Male; Middle Aged; Myeloid Progenitor Cells; Pyrroles; Solitary Fibrous Tumors; Sunitinib; Treatment Outcome; Tumor Microenvironment | 2014 |
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Autophagy; Drug Resistance, Neoplasm; Female; Humans; Indoles; Male; Pyrroles; Solitary Fibrous Tumors; Sunitinib; Transcriptome | 2016 |
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour.
Topics: Aged; Angiogenesis Inhibitors; Benzenesulfonates; Fatal Outcome; Female; Hemangiopericytoma; Humans; Indoles; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Recurrence; Solitary Fibrous Tumors; Sorafenib; Sunitinib; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Sunitinib malate in solitary fibrous tumor (SFT).
Topics: Adult; Aged; Angiogenesis Inhibitors; Antigens, CD34; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Retrospective Studies; Solitary Fibrous Tumors; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2012 |